AIM Immunotech Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AIM Immunotech Inc. on May 29, 2025, covering events occurring through June 12, 2025. The Company, incorporated in Delaware, is headquartered in Ocala, Florida. Its common stock is registered on the NYSE American under the symbol "AIM," though it was temporarily trading on the OTC Pink under the symbol "AIMID" prior to reinstatement.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance actions and listing status updates.
Material Changes
- Reverse Stock Split: On June 10, 2025, the Company filed an amendment to its Articles of Incorporation to effect a 1-for-100 reverse split of its outstanding common stock. This action was authorized by stockholders at a Special Meeting on April 30, 2025, and approved by the Board on May 29, 2025. Cash will be issued in lieu of fractional shares.
- Listing Reinstatement: On June 11, 2025, the NYSE American notified the Company that it regained compliance with the low selling price requirement (Section 1003(f)(v)). Trading is expected to resume on the Exchange on June 17, 2025, under the ticker symbol "AIM."
- Security Identification: A new CUSIP number (00901B303) has been assigned to the Company's common stock.
Outlook, Risks, and Management Commentary
The filing includes standard forward-looking statements regarding management's expectations for the reinstatement of trading and the reverse split. The Company explicitly disclaims any obligation to update these statements. Investors are directed to review risk factors in the most recent Form 10-K and subsequent filings. No specific financial guidance or operational outlook is provided in this document.
Investor Verification Checklist
- Confirm the effective date and execution of the 1-for-100 reverse stock split.
- Verify the resumption of trading on the NYSE American on June 17, 2025, under the symbol "AIM."
- Check the new CUSIP number (00901B303) for trading and settlement purposes.
- Review the attached press releases (Exhibits 99.1 and 99.2) for additional details on the delisting and reinstatement process.
- Consult the most recent Form 10-K for comprehensive risk factors and financial data not included in this 8-K.